Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2025-12-24 @ 3:25 PM
NCT ID:
NCT03004092
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 16y at start of study
* One of the following diagnoses:
* De novo, refractory or relapsed AML/MDS receiving intensive chemotherapy
* De novo, refractory or relapsed ALL/T-lymphoblastic lymphoma receiving intensive chemotherapy
* Aplastic anemia requiring ATG therapy
* Any patient admitted for either autologous or allogeneic hematopoietic stem cell transplantation
* Written informed consent obtained from the patient
Exclusion Criteria:
* AML or ALL beyond the specified inclusion criteria
* Directed treatment for possible, probable, or proven invasive aspergillosis, at moment of screening, or with end of treatment \< 6 weeks at screening, or no complete response according to EORTC/MSG criteria, or complete response achieved \< 6 weeks at time of screening.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT03004092
Study Brief:
Protocol Section:
NCT03004092